Sort by 'likes'
New Developments in Breast Cancer Screening and Treatment
Breast cancer is the second most common cancer in women (although men can get it too). Some breast cancers are driven by inherited mutations while most are sporadic, driven by unknown causes or by environmental or behavioral factors like obesity,…
Melflufen for Myeloma: A Deep Dive
The FDA recently granted priority review to a new drug application for melflufen (INN melphalan flufenamide), in combination with dexamethasone. Melflufen is intended for use as a first choice for patients with multiple myeloma whose disease is refractory to at…
PCOS & Menstrual Cycle – A PCOS Community Q&A Session
PCOS is an enigmatic disease with the most common symptoms being irregular menstrual cycles and ovulation leading to infertility in many cases. We created a PCOS Tracker, a free app for women to track their PCOS symptoms, and as it…
Beating Leukemia with Groundbreaking CAR-T Cell Therapy
Dr. Stephan A. Grupp made history when he treated the first child with CAR T cell therapy, Emily Whitehead, who is now more than five years cancer-free. In CAR-T cell therapy, a patient's own genetically altered immune cells fight cancer.…
Treatments for Early Stage Plasma Cell Disorders
Plasma cell disorders like multiple myeloma, plasmacytoma, smoldering myeloma, MGUS are diseases in which the body makes too many plasma cells. These disorders have different symptoms, treatments, and prognoses. The myeloma panel is talking to Dr. Craig Hofmeister from Winship…